News

The American Journal of Managed Care1d
Semaglutide Shows Promise for MASH Resolution, Severe Fibrosis: Naim Alkhouri, MD
Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...
Healio10d
Semaglutide tied to significant improvements in MASH, liver fibrosis at 72 weeks
Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...
PR Newswire17d
Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets™
April 24, 2025 /PRNewswire/ -- The global Oral Proteins & Peptides Market ... drugs like semaglutide, which have significant potential applications. AbbVie Inc. (US): AbbVie Inc. holds the ...